Eumovate® (Clobetasone Butyrate 0.05% Cream and Ointment) - A - Detailing from Skin Therapy Letter

 

Eumovate® (Clobetasone Butyrate 0.05% Cream and Ointment)

 

 

  Content:

EFFICACY

 

 

  • Clobetasone butyrate 0.05% cream with its moisturizing emollient base is reported to provide better healing properties than hydrocortisone 1% cream. Its high glycerol content promotes skin hydration and protects and moisturizes the skin.
  • [J Dermatol Treat. 2001 Dec;12(4):191-7.]

  • has no demonstrated potential for skin thinning vs. 1% hydrocortisone.
  • [GSK product monograph]

  • has negligible systemic absorption and effect on HOP axis function.
  • [GSK product monograph]

  • has minimal side effects even in children under 2.
  • [GSK product monograph]

  • has a high glycerol content which promotes skin hydration and absorption.
  • [J Dermatol Treat. 2001 Dec; 12(4):191-7.]

  • contains dimethicone to protect and moisturize the skin.
  • [J Dermatol Treat. 2001 Dec; 12(4):191-7.]

  • The emollient base used for Eumovate® cream offers better healing properties than 1% hydrocortisone.
  • [J Dermatol Treat. 2001 Dec; 12(4):191-7.]


Next:   Compliance